131 related articles for article (PubMed ID: 18185490)
1. Advances in the treatment of T-cell lymphoma. A review of presentations from the 48th annual meeting of the American Society of Hematology, December 9-12, 2006, Orlando, Florida, USA.
Clin Adv Hematol Oncol; 2007 Oct; 5(10 Suppl 16):1-10; quiz 11-12. PubMed ID: 18185490
[No Abstract] [Full Text] [Related]
2. American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USA.
Talmadge JE
IDrugs; 2007 Feb; 10(2):87-9. PubMed ID: 17285455
[No Abstract] [Full Text] [Related]
3. Recent Advances in the Treatment of MDS. A review of selected presentations from the 48th Annual Meeting of the American Society of Hematology, December 9-12, 2006, Orlando, Florida.
Garcia-Manero G
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 6):1-13; quiz 15-6. PubMed ID: 17519888
[No Abstract] [Full Text] [Related]
4. 43rd Annual Meeting of the American Society of Hematology, December 7-11, 2001, Orlando, Florida.
D'Orazio AI; Fisher MD
Clin Lymphoma; 2002 Mar; 2(4):205-8. PubMed ID: 11970758
[No Abstract] [Full Text] [Related]
5. Abstracts of the American Society of Hematology 48th Annual Meeting, December 9-12, 2006, Orlando, Florida, USA.
Blood; 2006 Nov; 108(11 Pt 2):3b-482b. PubMed ID: 17171810
[No Abstract] [Full Text] [Related]
6. Abstracts of the American Society of Hematology 48th Annual Meeting, December 9-12, 2006, Orlando, Florida, USA.
Blood; 2006 Nov; 108(11 Pt 1):1a-1062a. PubMed ID: 17139767
[No Abstract] [Full Text] [Related]
7. American Society of Hematology--48th Annual Meeting and Exposition. 9-12 December 2006, Orlando, FL, USA.
Walker K
IDrugs; 2007 Feb; 10(2):75-7. PubMed ID: 17285451
[No Abstract] [Full Text] [Related]
8. American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA.
Tear S
IDrugs; 2007 Feb; 10(2):84-6. PubMed ID: 17285454
[No Abstract] [Full Text] [Related]
9. American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA.
Walker K
IDrugs; 2007 Feb; 10(2):78-80. PubMed ID: 17285452
[No Abstract] [Full Text] [Related]
10. 9th Annual International Congress on Hematologic Malignancies, Whistler, BC, Canada; 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, FL; 46th Annual Meeting of the American Society of Hematology, San Diego, CA.
Reddy GK; Tyagi P
Clin Lymphoma; 2005 Jun; 6(1):4-10. PubMed ID: 15989700
[No Abstract] [Full Text] [Related]
11. Recent advances in the treatment of leukemia, lymphoma, and myeloma. [Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition. December 4–7, 2010. Orlando, Florida].
Cheson BD
Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 7):1-24. PubMed ID: 21558999
[No Abstract] [Full Text] [Related]
12. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
[No Abstract] [Full Text] [Related]
13. American Society of Hematology--48th Annual Meeting and Exposition. The Factor Xa target, and disorders of platelet number and function. 9-12 December 2006 Orlando, FL, USA.
Tear S
IDrugs; 2007 Feb; 10(2):81-3. PubMed ID: 17285453
[No Abstract] [Full Text] [Related]
14. Abstracts of the American Society of Hematology 52nd Annual Meeting, December 4-7, 2010, Orlando, Florida, USA.
Blood; 2010 Nov; 116(21):3-1767. PubMed ID: 22276300
[No Abstract] [Full Text] [Related]
15. American Society of Hematology 43rd Annual Meeting. December 7-11, 2001. Orlando, Florida, USA. Abstracts.
Blood; 2001 Nov; 98(11 Pt 1):1a-953a. PubMed ID: 11727739
[No Abstract] [Full Text] [Related]
16. American Society of Hematology 43rd Annual Meeting. December 7-11, 2001. Orlando, Florida, USA. Abstracts.
Blood; 2001 Nov; 98(11 Pt 2):1b-416b. PubMed ID: 11727738
[No Abstract] [Full Text] [Related]
17. Highlights in Lymphoma From the 2015 ASH Meeting: Commentary.
Chen RW
Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):18-23. PubMed ID: 27007009
[No Abstract] [Full Text] [Related]
18. Highlights in T-cell lymphoma from the 2011 American Society of Hematology Annual Meeting and Exposition.
Horwitz SM
Clin Adv Hematol Oncol; 2012 Mar; 10(3 Suppl 3):1-24. PubMed ID: 22398731
[No Abstract] [Full Text] [Related]
19. Recent advances in the treatment of T-cell lymphomas.
Clin Adv Hematol Oncol; 2010 Feb; 8(2 Suppl 4):1-10; discussion 11-3; quiz 15-6. PubMed ID: 20448525
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified.
Hirata Y; Yokote T; Kobayashi K; Nakayama S; Miyoshi T; Akioka T; Hara S; Tsuji M; Takubo T; Hanafusa T
Leuk Res; 2009 Jun; 33(6):e13-6. PubMed ID: 18995899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
